Cargando…
Effect of an inactivated coronavirus disease 2019 vaccine, CoronaVac, on blood coagulation and glucose: a randomized, controlled, open-label phase IV clinical trial
BACKGROUND: Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered and several cases of thrombocytopenia with thrombosis syndrome (TTS) have been reported after the administration of adenoviral vector vaccines. However, the effects of an inactivated COVID-19 vaccine...
Autores principales: | Xu, Qing, Lu, Xi, Liu, Xiaodong, Zhao, Yanwei, Sun, Dapeng, Cao, Qingfan, Liu, Haidong, Yang, Tuantuan, Song, Yufei, Lv, Jingjing, Xiong, Ping, Li, Jing, Sun, Jianwen, Xie, Meng, Gao, Yongjun, Zhang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265469/ https://www.ncbi.nlm.nih.gov/pubmed/37325662 http://dx.doi.org/10.3389/fimmu.2023.1122651 |
Ejemplares similares
-
Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022) -
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
por: Samoud, Samar, et al.
Publicado: (2023) -
CoronaVac efficacy data from Turkey
por: McMenamin, Martina E, et al.
Publicado: (2021) -
Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial
por: Li, Jingxin, et al.
Publicado: (2022) -
Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial
por: Zhu, Dandan, et al.
Publicado: (2022)